US Stock MarketDetailed Quotes

CARM Carisma Therapeutics

Watchlist

0.418
-0.024-5.35%

Close Dec 20 16:00 ET

0.426
+0.009+2.03%

Post 20:05 ET

17.45MMarket Cap-0.27P/E (TTM)

Carisma Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

-11.55%3.39M

158.34%9.2M

4.75%3.4M

51.71%14.92M

14.96%4.29M

48.45%3.83M

31.71%3.56M

294.53%3.24M

9.83M

3.73M

Operating revenue

-11.55%3.39M

158.34%9.2M

4.75%3.4M

51.71%14.92M

14.96%4.29M

48.45%3.83M

31.71%3.56M

294.53%3.24M

--9.83M

--3.73M

Cost of revenue

Gross profit

Operating expense

-36.84%16.53M

-14.92%20.87M

-12.62%22.91M

57.05%103.65M

40.34%26.74M

35.40%26.17M

47.42%24.53M

138.80%26.22M

61.78%66M

19.05M

Selling and administrative expenses

-21.40%5.2M

-7.44%5.56M

-43.13%5.45M

214.83%29.53M

654.27%7.32M

75.50%6.62M

147.81%6.01M

333.02%9.57M

46.37%9.38M

--971K

-General and administrative expense

-21.40%5.2M

-7.44%5.56M

-43.13%5.45M

214.83%29.53M

654.27%7.32M

75.50%6.62M

147.81%6.01M

333.02%9.57M

46.37%9.38M

--971K

Research and development costs

-42.07%11.33M

-17.34%15.31M

4.93%17.46M

30.92%74.13M

7.37%19.42M

25.67%19.55M

30.30%18.52M

89.81%16.64M

64.65%56.62M

--18.08M

Operating profit

41.17%-13.14M

44.34%-11.67M

15.07%-19.51M

-57.99%-88.73M

-46.52%-22.45M

-33.39%-22.34M

-50.47%-20.97M

-126.19%-22.97M

-37.67%-56.16M

-15.32M

Net non-operating interest income expense

-53.03%442K

-56.84%508K

136.02%532K

161.56%1.94M

249.37%1.3M

203.63%941K

252.66%1.18M

-146.58%-1.48M

-31,550.00%-3.15M

-867K

Non-operating interest income

----

--1.94M

----

Non-operating interest expense

----

--3.15M

----

Total other finance cost

53.03%-442K

56.84%-508K

-136.02%-532K

----

-203.63%-941K

-252.66%-1.18M

146.58%1.48M

----

Other net income (expense)

95.62%-84K

84.92%-84K

-1.92M

-550K

Gain on sale of security

----

95.62%-84K

--0

----

84.92%-84K

---1.92M

---550K

Income before tax

40.65%-12.7M

43.59%-11.16M

22.64%-18.98M

-41.90%-86.88M

-26.38%-21.16M

-16.78%-21.4M

-33.27%-19.79M

-116.88%-24.53M

-50.12%-61.23M

-16.74M

Income tax

88K

109K

Net income

40.65%-12.7M

43.84%-11.16M

22.99%-18.98M

-41.90%-86.88M

-25.20%-20.96M

-16.78%-21.4M

-33.86%-19.88M

-117.84%-24.64M

-50.12%-61.23M

-16.74M

Net income continuous Operations

40.65%-12.7M

43.84%-11.16M

22.99%-18.98M

-41.90%-86.88M

-25.20%-20.96M

-16.78%-21.4M

-33.86%-19.88M

-117.84%-24.64M

-50.12%-61.23M

---16.74M

Minority interest income

Net income attributable to the parent company

40.65%-12.7M

43.84%-11.16M

22.99%-18.98M

-41.90%-86.88M

-25.20%-20.96M

-16.78%-21.4M

-33.86%-19.88M

-117.84%-24.64M

-50.12%-61.23M

-16.74M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

40.65%-12.7M

43.84%-11.16M

22.99%-18.98M

-41.90%-86.88M

-25.20%-20.96M

-16.78%-21.4M

-33.86%-19.88M

-117.84%-24.64M

-50.12%-61.23M

-16.74M

Basic earnings per share

41.51%-0.31

44.90%-0.27

76.17%-0.46

-70.29%-2.59

-15.43%-0.48

-16.41%-0.53

-32.84%-0.49

-586.81%-1.93

-50.12%-1.521

-0.4158

Diluted earnings per share

41.51%-0.31

44.90%-0.27

76.17%-0.46

-70.29%-2.59

-15.43%-0.48

-16.41%-0.53

-32.84%-0.49

-586.81%-1.93

-50.12%-1.521

-0.4158

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	-11.55%3.39M	158.34%9.2M	4.75%3.4M	51.71%14.92M	14.96%4.29M	48.45%3.83M	31.71%3.56M	294.53%3.24M	9.83M	3.73M
Operating revenue	-11.55%3.39M	158.34%9.2M	4.75%3.4M	51.71%14.92M	14.96%4.29M	48.45%3.83M	31.71%3.56M	294.53%3.24M	--9.83M	--3.73M
Cost of revenue
Gross profit
Operating expense	-36.84%16.53M	-14.92%20.87M	-12.62%22.91M	57.05%103.65M	40.34%26.74M	35.40%26.17M	47.42%24.53M	138.80%26.22M	61.78%66M	19.05M
Selling and administrative expenses	-21.40%5.2M	-7.44%5.56M	-43.13%5.45M	214.83%29.53M	654.27%7.32M	75.50%6.62M	147.81%6.01M	333.02%9.57M	46.37%9.38M	--971K
-General and administrative expense	-21.40%5.2M	-7.44%5.56M	-43.13%5.45M	214.83%29.53M	654.27%7.32M	75.50%6.62M	147.81%6.01M	333.02%9.57M	46.37%9.38M	--971K
Research and development costs	-42.07%11.33M	-17.34%15.31M	4.93%17.46M	30.92%74.13M	7.37%19.42M	25.67%19.55M	30.30%18.52M	89.81%16.64M	64.65%56.62M	--18.08M
Operating profit	41.17%-13.14M	44.34%-11.67M	15.07%-19.51M	-57.99%-88.73M	-46.52%-22.45M	-33.39%-22.34M	-50.47%-20.97M	-126.19%-22.97M	-37.67%-56.16M	-15.32M
Net non-operating interest income expense	-53.03%442K	-56.84%508K	136.02%532K	161.56%1.94M	249.37%1.3M	203.63%941K	252.66%1.18M	-146.58%-1.48M	-31,550.00%-3.15M	-867K
Non-operating interest income	----	----	----	--1.94M	----	----	----	----	----	----
Non-operating interest expense	----	----	----	----	----	----	----	----	--3.15M	----
Total other finance cost	53.03%-442K	56.84%-508K	-136.02%-532K	----	----	-203.63%-941K	-252.66%-1.18M	146.58%1.48M	----	----
Other net income (expense)				95.62%-84K	0			84.92%-84K	-1.92M	-550K
Gain on sale of security	----	----	----	95.62%-84K	--0	----	----	84.92%-84K	---1.92M	---550K
Income before tax	40.65%-12.7M	43.59%-11.16M	22.64%-18.98M	-41.90%-86.88M	-26.38%-21.16M	-16.78%-21.4M	-33.27%-19.79M	-116.88%-24.53M	-50.12%-61.23M	-16.74M
Income tax	0	0	0			0	88K	109K
Net income	40.65%-12.7M	43.84%-11.16M	22.99%-18.98M	-41.90%-86.88M	-25.20%-20.96M	-16.78%-21.4M	-33.86%-19.88M	-117.84%-24.64M	-50.12%-61.23M	-16.74M
Net income continuous Operations	40.65%-12.7M	43.84%-11.16M	22.99%-18.98M	-41.90%-86.88M	-25.20%-20.96M	-16.78%-21.4M	-33.86%-19.88M	-117.84%-24.64M	-50.12%-61.23M	---16.74M
Minority interest income
Net income attributable to the parent company	40.65%-12.7M	43.84%-11.16M	22.99%-18.98M	-41.90%-86.88M	-25.20%-20.96M	-16.78%-21.4M	-33.86%-19.88M	-117.84%-24.64M	-50.12%-61.23M	-16.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	40.65%-12.7M	43.84%-11.16M	22.99%-18.98M	-41.90%-86.88M	-25.20%-20.96M	-16.78%-21.4M	-33.86%-19.88M	-117.84%-24.64M	-50.12%-61.23M	-16.74M
Basic earnings per share	41.51%-0.31	44.90%-0.27	76.17%-0.46	-70.29%-2.59	-15.43%-0.48	-16.41%-0.53	-32.84%-0.49	-586.81%-1.93	-50.12%-1.521	-0.4158
Diluted earnings per share	41.51%-0.31	44.90%-0.27	76.17%-0.46	-70.29%-2.59	-15.43%-0.48	-16.41%-0.53	-32.84%-0.49	-586.81%-1.93	-50.12%-1.521	-0.4158
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Heat List

Overall

No Data